NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
16.41
+0.01 (0.06%)
At close: Dec 20, 2024, 4:00 PM
16.51
+0.10 (0.61%)
After-hours: Dec 20, 2024, 6:31 PM EST
NeoGenomics Employees
NeoGenomics had 2,100 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$306,723
Profits / Employee
-$37,013
Market Cap
2.11B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CONMED | 4,000 |
Omnicell | 3,650 |
Premier | 2,900 |
GeneDx Holdings | 1,000 |
LeMaitre Vascular | 630 |
Beam Therapeutics | 436 |
Agios Pharmaceuticals | 386 |
IDEAYA Biosciences | 124 |
NEO News
- 10 days ago - NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma - Business Wire
- 12 days ago - NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting - Business Wire
- 16 days ago - ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research - Business Wire
- 4 weeks ago - NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Business Wire
- 5 weeks ago - Felicia Williams Joins NeoGenomics Board of Directors - Business Wire
- 6 weeks ago - NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 6 weeks ago - NeoGenomics, Inc. (NEO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - NeoGenomics Reports Third Quarter 2024 Results - Business Wire